trial · primary record
TC-N201 cells
Advanced Solid Tumors
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2028-12 |
| Primary endpoint | Dose Limiting Toxicity or Maximum Tolerated Dose (MTD) |
| Registry ID | NCT05881525 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T03:28:37.796Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05881525
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.